U.S. RESEARCH ROUNDUP-Adapthealth, Carnival, Phunware

Aemetis

02/09/2024 08:23

Sept 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies including Adapthealth, Carnival and Phunware, on Monday. 
    
      HIGHLIGHTS 
  

                 * Adapthealth Corp  AHCO.O : Leerink Partners cuts target price to $13 from $14
 
                 * Ardent Health Partners Inc  ARDT.N : JP Morgan raises target price to $19 from $18
 
                 * Carnival Corp  CCL.N : HSBC raises target price to $14 from $13
 
                 * Miniso Group Holding Ltd  MNSO.N : JP Morgan cuts target price to $27 from $29
 
                 * Phunware Inc  PHUN.O : Ascendiant Capital Markets cuts target price to $20 from $22
 
       
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in
alphabetical order.
    
                 * Adapthealth Corp  AHCO.O : Leerink Partners cuts target price to $13 from $14
 
                 * Aemetis Inc  AMTX.O : Ascendiant Capital Markets cuts target price to $19 from $20
 
                 * Aim Immunotech Inc  AIM.A : Ascendiant Capital Markets cuts PT to $5 from $5.25
 
                 * Ardent Health Partners Inc  ARDT.N : JP Morgan raises target price to $19 from $18
 
                 * Carnival Corp  CCL.N : HSBC raises target price to $14 from $13
 
                 * CF Industries Holdings Inc  CF.N : Berenberg raises target price to $69 from $67
 
                 * IGC Pharma Inc  IGC.A : Ascendiant Capital Markets raises PT to $3.75 from $3.5
 
                 * Miniso Group Holding Ltd  MNSO.N : JP Morgan cuts target price to $27 from $29
 
                 * Outlook Therapeutics Inc  OTLK.O : Ascendiant Capital Markets cuts PT to $33 from $35
 
                 * Phunware Inc  PHUN.O : Ascendiant Capital Markets cuts target price to $20 from $22
 
                 * Plus Therapeutics Inc  PSTV.O : Ascendiant Capital Markets cuts PT to $20 from $21
 
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))